Alzheimer’s Drug Slows Cognitive Decline in Key Study



Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.



Source link

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart